Francoise Collin

Dijon, 21000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.

Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.

Journal: Cancers

Published: November 24, 2022

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.

Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.

Journal: Scientific reports

Published: June 22, 2021

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.

Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.

Journal: PloS one

Published: June 20, 2020

Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas.

Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: March 28, 2019

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

Journal: EBioMedicine

Published: December 11, 2018

Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.

Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.

Journal: Cancer medicine

Published: April 16, 2018

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

Journal: Cancer

Published: September 22, 2017

Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.

Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 23, 2017

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Journal: Oncoimmunology

Published: November 23, 2016

Sarcoma developed in irradiated area: Preliminary results of the SARI trial

Sarcoma developed in irradiated area: Preliminary results of the SARI trial

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: July 07, 2016

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 06, 2015

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 16, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026